APO-LEFLUNOMIDE leflunomide 20mg tablets bottle

Land: Australien

Sprog: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv bestanddel:

leflunomide, Quantity: 20 mg

Tilgængelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Leflunomide

Lægemiddelform:

Tablet, uncoated

Sammensætning:

Excipient Ingredients: colloidal anhydrous silica; lactose; magnesium stearate; crospovidone

Indgivelsesvej:

Oral

Enheder i pakken:

30 tablets

Recept type:

(S4) Prescription Only Medicine

Terapeutiske indikationer:

Apo-Leflunomide is indicated for the treatment of active rheumatoid arthritis. The combined use of Apo-Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Produkt oversigt:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisation status:

Licence status A

Autorisation dato:

2011-07-22